PUFA stabilizes a conductive state of the selectivity filter in IKs channels.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
31 Oct 2024
Historique:
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 31 10 2024
Statut: epublish

Résumé

In cardiomyocytes, the KCNQ1/KCNE1 channel complex mediates the slow delayed-rectifier current (IKs), pivotal during the repolarization phase of the ventricular action potential. Mutations in IKs cause long QT syndrome (LQTS), a syndrome with a prolonged QT interval on the ECG, which increases the risk of ventricular arrhythmia and sudden cardiac death. One potential therapeutical intervention for LQTS is based on targeting IKs channels to restore channel function and/or the physiological QT interval. Polyunsaturated fatty acids (PUFAs) are potent activators of KCNQ1 channels and activate IKs channels by binding to two different sites, one in the voltage sensor domain - which shifts the voltage dependence to more negative voltages - and the other in the pore domain - which increases the maximal conductance of the channels (Gmax). However, the mechanism by which PUFAs increase the Gmax of the IKs channels is still poorly understood. In addition, it is unclear why IKs channels have a very small single-channel conductance and a low open probability or whether PUFAs affect any of these properties of IKs channels. Our results suggest that the selectivity filter in KCNQ1 is normally unstable, contributing to the low open probability, and that the PUFA-induced increase in Gmax is caused by a stabilization of the selectivity filter in an open-conductive state. Travelling through the heart are waves of electrical activity that cause muscle cells to contract and pump blood around the body. The waves are generated by charged ions which flow via tiny channels in and out of the muscle cells. This electrical activity spreads quickly from one cell to the next to make sure all the muscle cells contract at the right time. When these ion channels are compromised, this can lead to heart problems such as long QT syndrome (LQTS). In patients with LQTS, electrical activity in the heart does not follow the typical rhythm, which can result in an irregular heartbeat and lead to cardiac arrest. The most common cause of LQTS is mutations in the channel KCNQ1, which allows potassium ions to flow out of heart muscle cells. This outflux of potassium restores the electrical charge inside the cell so that it is ready to receive another electrical wave and contract at the right time. Current treatments for LQTS do not target KCNQ1 channels directly and have side effects. An alternative approach could be to use a group of molecules called polyunsaturated fatty acids (or PUFAs for short) which increase the flow of ions that pass through KCNQ1. However, it is not fully understood how PUFAs achieve this. Previous research showed that PUFAs activate KCNQ1 via two independent sites: one at the voltage sensor which decides whether the channel is open or closed (Site I), and another at the pore domain ions pass through (Site II). While it is well understood how PUFAs activate the channel at Site I, little is known about the activation mechanism that occurs at Site II. To investigate, Golluscio et al. modified egg cells from the frog

Autres résumés

Type: plain-language-summary (eng)
Travelling through the heart are waves of electrical activity that cause muscle cells to contract and pump blood around the body. The waves are generated by charged ions which flow via tiny channels in and out of the muscle cells. This electrical activity spreads quickly from one cell to the next to make sure all the muscle cells contract at the right time. When these ion channels are compromised, this can lead to heart problems such as long QT syndrome (LQTS). In patients with LQTS, electrical activity in the heart does not follow the typical rhythm, which can result in an irregular heartbeat and lead to cardiac arrest. The most common cause of LQTS is mutations in the channel KCNQ1, which allows potassium ions to flow out of heart muscle cells. This outflux of potassium restores the electrical charge inside the cell so that it is ready to receive another electrical wave and contract at the right time. Current treatments for LQTS do not target KCNQ1 channels directly and have side effects. An alternative approach could be to use a group of molecules called polyunsaturated fatty acids (or PUFAs for short) which increase the flow of ions that pass through KCNQ1. However, it is not fully understood how PUFAs achieve this. Previous research showed that PUFAs activate KCNQ1 via two independent sites: one at the voltage sensor which decides whether the channel is open or closed (Site I), and another at the pore domain ions pass through (Site II). While it is well understood how PUFAs activate the channel at Site I, little is known about the activation mechanism that occurs at Site II. To investigate, Golluscio et al. modified egg cells from the frog

Identifiants

pubmed: 39480699
doi: 10.7554/eLife.95852
pii: 95852
doi:
pii:

Substances chimiques

KCNQ1 Potassium Channel 0
Fatty Acids, Unsaturated 0
Potassium Channels, Voltage-Gated 0
KCNQ1 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : 5R01HL131461
Pays : United States
Organisme : Heart and Stroke Foundation of Canada
ID : G-21-0031566
Organisme : CIHR
ID : PJT-180245
Pays : Canada
Organisme : CIHR
ID : PJT-175024
Pays : Canada
Organisme : Natural Sciences and Engineering Research Council of Canada
ID : RGPIN-2022-03021

Informations de copyright

© 2024, Golluscio et al.

Déclaration de conflit d'intérêts

AG, JE, JJ, MP, KC, AD, XW, VC, DT, DF, HL No competing interests declared

Références

Elife. 2016 Jan 23;5:
pubmed: 26802629
J Gen Physiol. 1997 Jun;109(6):779-89
pubmed: 9222903
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):E996-1005
pubmed: 23431135
Prog Biophys Mol Biol. 2006 Oct;92(2):185-208
pubmed: 16316679
Biophys J. 2011 Aug 17;101(4):818-27
pubmed: 21843472
J Gen Physiol. 2020 Feb 3;152(2):
pubmed: 31865382
Card Electrophysiol Clin. 2016 Jun;8(2):275-84
pubmed: 27261821
Physiol Rev. 2005 Oct;85(4):1205-53
pubmed: 16183911
Biophys J. 2008 Sep;95(5):2242-53
pubmed: 18502799
Circulation. 2000 Sep 5;102(10):1178-85
pubmed: 10973849
Front Physiol. 2020 Jun 11;11:641
pubmed: 32595524
Circ Arrhythm Electrophysiol. 2018 Oct;11(10):e006558
pubmed: 30354408
J Gen Physiol. 2011 Jun;137(6):563-77
pubmed: 21624947
Biochim Biophys Acta. 2002 Oct 11;1565(2):294-307
pubmed: 12409202
Biophys J. 2011 May 18;100(10):2387-93
pubmed: 21575572
Elife. 2023 Jun 23;12:
pubmed: 37350568
N Engl J Med. 2008 Jan 10;358(2):169-76
pubmed: 18184962
J Gen Physiol. 2021 Dec 6;153(12):
pubmed: 34636894
J Gen Physiol. 2021 Jun 7;153(6):
pubmed: 33939797
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5714-9
pubmed: 25901329
Elife. 2013 Dec 10;2:e01289
pubmed: 24327560
Cell Rep. 2018 Sep 11;24(11):2908-2918
pubmed: 30208316
Biophys J. 1994 Apr;66(4):1061-7
pubmed: 8038378
J Gen Physiol. 2023 Oct 2;155(10):
pubmed: 37526928
Proc Natl Acad Sci U S A. 2023 May 23;120(21):e2301985120
pubmed: 37192161
Front Physiol. 2017 Feb 06;8:43
pubmed: 28220076
Int J Mol Sci. 2020 Dec 11;21(24):
pubmed: 33322401
Nature. 1996 Nov 7;384(6604):80-3
pubmed: 8900283
Acta Physiol (Oxf). 2019 Feb;225(2):e13186
pubmed: 30184322
Nutrients. 2021 Jun 23;13(7):
pubmed: 34201625
Neuron. 2000 Sep;27(3):573-83
pubmed: 11055439
J Gen Physiol. 2023 May 1;155(5):
pubmed: 36809486
Methodist Debakey Cardiovasc J. 2014 Jan-Mar;10(1):29-33
pubmed: 24932360
Nature. 1996 Nov 7;384(6604):78-80
pubmed: 8900282
Science. 1998 Apr 3;280(5360):69-77
pubmed: 9525859

Auteurs

Alessia Golluscio (A)

Department of Physiology and Biophysics, University of Miami, Miami, United States.
Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Jodene Eldstrom (J)

Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada.

Jessica J Jowais (JJ)

Department of Physiology and Biophysics, University of Miami, Miami, United States.

Marta Elena Perez (ME)

Department of Physiology and Biophysics, University of Miami, Miami, United States.

Kevin Peter Cunningham (KP)

Department of Physiology and Biophysics, University of Miami, Miami, United States.
School of Life Sciences, University of Westminster, London, United Kingdom.

Alicia De La Cruz (A)

Department of Physiology and Biophysics, University of Miami, Miami, United States.
Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Xiaoan Wu (X)

Department of Physiology and Biophysics, University of Miami, Miami, United States.

Valentina Corradi (V)

Department of Biological Sciences and Centre for Molecular Simulation, University of Calgary, Calgary, Canada.

D Peter Tieleman (DP)

Department of Biological Sciences and Centre for Molecular Simulation, University of Calgary, Calgary, Canada.

David Fedida (D)

Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada.

H Peter Larsson (HP)

Department of Physiology and Biophysics, University of Miami, Miami, United States.
Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH